Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone–marrow transplant patients without risking increased bleeding, according to new research. Blood platelet shortages are a big problem in blood banking. The basic conclusion of the research was that fewer platelets could be used and that would have a societal benefit because, by using less platelets for oncology patients, more platelets would be available to other people who needed them. ... Click Here to Read More Click Here to Read More
